Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
European Journal of Pharmacology|April 3, 2013
Intra-arterial radioembolization of breast cancer liver metastases: a structured reviewMaarten L J Smits, Jip F Prince, Charlotte E N M Rosenbaum, et al.Neurology|August 10, 2012
Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau diseaseCarlijn Frantzen, Roeliene C Kruizinga, Sophie J van Asselt, et al.Lancet (London, England)|January 15, 2013
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trialJohn J Bissler, J Christopher Kingswood, Elżbieta Radzikowska, et al.European Journal of Endocrinology|February 18, 2016
Potential value of EUS in pancreatic surveillance of VHL patientsSophie J van Asselt, Adrienne H Brouwers, Hendrik M van Dullemen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2017
Efficacy of Radioembolization with 166Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 StudyJip F Prince, Maurice A A J van den Bosch, Johannes F W Nijsen, et al.Journal of Experimental & Clinical Cancer Research : CR|June 17, 2010
Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trialMaarten L J Smits, Johannes F W Nijsen, Maurice A A J van den Bosch, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2013
In vivo dosimetry based on SPECT and MR imaging of 166Ho-microspheres for treatment of liver malignanciesMaarten L J Smits, Mattijs Elschot, Maurice A A J van den Bosch, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2016
89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau DiseaseSjoukje F Oosting, Sophie J van Asselt, Adrienne H Brouwers, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 19, 2011
Compliance with periodic surveillance for Von-Hippel-Lindau diseaseChantal R M Lammens, Neil K Aaronson, Frederik J Hes, et al.Neuro-Oncology|December 24, 2010
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to responseWalter Taal, Hendrikus J Dubbink, Chris B L Zonnenberg, et al.Pageof 7